Beta-thalassemia with Transfusional Iron Overload
📧 Sign up to get email alerts when something new happens for Beta-thalassemia with Transfusional Iron Overload.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-12-14FDA Approved: DEFEROXAMINE MESYLATE — Supplemental Application (Hospira, Inc.)
FDA approved Hospira's supplemental application for Deferoxamine Mesylate, enabling its continued marketing as an iron chelation therapy.